Amgen
The main objective of this study is to compare the relative bioavailability, safety, and tolerability of extended-release and immediate-release apremilast formulations in healthy participants.
Inclusion Criteria: * Healthy male or female participants, 18 to 60 years of age, inclusive. * Body mass index (BMI) between 18.0 and 32.0 kg/m\^²(kilograms per meter square.), inclusive. * In good health as determined by medical history, physical examination, vital signs, electrocardiogram (ECG), and clinical laboratory evaluations. * Female participants must not be pregnant or breastfeeding. * Participants of reproductive potential must agree to follow protocol-specified contraception requirements. Exclusion Criteria: * Clinically significant medical condition or disease that may pose a s…
Participants will receive apremilast XR orally.
Participants will receive apremilast IR orally .
Arctuva estimate
Actual pay is set by the research site.
Verify or correct the compensation shown for this listing.